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Thank you for submitting your manuscript to the EMBO Journal. Your study has now been seen by three referees and their comments are provided below.
As you can see the referees appreciate the findings reported, but also find that some further analysis is needed to strengthen the findings reported. In particular, better support for that the autoimmunity phenotype observed is linked to a specific defect in negative selection is needed. Given the referees' positive recommendations, I would like to invite you to submit a revised version of the manuscript that addresses the concerns raised in full. I should add that it is EMBO Journal policy to allow only a single round of revision and it is therefore important to address the raised concerns in full.
When preparing your letter of response to the referees' comments, please bear in mind that this will form part of the Review Process File, and will therefore be available online to the community. For more details on our Transparent Editorial Process, please visit our website: http://www.nature.com/emboj/about/process.html
Thank you for the opportunity to consider your work for publication. I look forward to your revision.
Yours sincerely,
Editor
The EMBO Journal
REFEREE REPORTS
Referee #1
This manuscript builds upon the known function of HDAC7 in thymic negative selection by extending these results to the in vivo context. The authors show a major defect in negative selection (with notable caveats below). While this result is in line with previous in vitro data, the major novelty of the data is in the severity of the resulting autoimmunity. B6 mice are generally highly resistant to autoimmunity, with genetic defects in Aire, Bim, Fas or other negative-selection mediators resulting in relatively mild autoimmunity. The level of autoimmunity observed in the HDAC7-delP mice is equivalent to that observed in "double deficient" mice, indicating either the higher importance of HDAC7 to negative selection, or the role of HDAC7 in additional T cell tolerance processes (such as anergy).
While the data showing the severity of dominant T cell-dependent autoimmunity ( Figures 5-7 ) is very convincing, there are several major issues with the data linking this autoimmunity to a specific defect in negative selection:
Firstly, the method of presenting the data on negative selection in Figure 1 -2 is ambiguous. The results in figure 2 clearly show a defect in negative selection in HDAC7-delP mice, using two different transgenic systems, the HY-TCR (against male antigen) and the OT-II (anti-OVA, crossed to Act-OVA). In both cases there was a clear defect in negative selection. However this needs to be shown using the context of no negative selection, ie, side-by-side with female HY-TCR transgenics and OT-II TCR transgenics without OVA. This would allow a more quantitative assessment of the defect in negative selection to be made, ie, does HDAC7-delP reduce the efficiency of negative selection by 10%, 50% or 90%? This question becomes directly relevant in the next section of the paper, which discusses the "much more subtle" effect on HDAC7-delP on positive selection. In the manuscript the effect of HDAC7-delP is said to increase SP number and have no effect on DP-SP transition, however the representative plots in Figure 2E suggest ~50% defect in positive selection efficiency. This discrepancy comes from the increase in absolute numbers of the thymus of HDAC7-delP, making the absolute numbers of SP cells slightly higher, however this is an unusual definition of positive selection, which is typically defined as the transition between DP and SP cells. Using this more conventional definition, the results would be interpreted as a ~50% defect in positive selection (assuming the representative plots are truly representative, statistical analysis is not presented for this data). Thus it becomes highly relevant to quantify the defect in negative selection, is it on the same order as the defect in positive selection, or greater?
Secondly, the transcriptional data in Figures 3-4 is suggestive of a negative selection-specific defect, but this result is muddied by the technical system used to induce negative selection (i.p. peptide injection into TCR transgenic mice). In this system the death of thymocytes seen in this system could be secondary due to the massive peripheral activation of T cells. As such, either a peripheral defect in activation or a thymic defect in negative selection could manifest with similar changes in transcriptional profile in the thymus. This experimental design is therefore hard to place in context, without unambiguous data showing the negative selection is profoundly more impeded than positive selection and peripheral activation.
Finally, on the peripheral consequence of the negative selection defect, the authors "assume" that the defect in negative selection translates into increased autoreactive peripheral T cells; it is surprisingly that they do not show peripheral data for their TCR transgenic systems which could actually demonstrate this point. An increase in CD69 expression and activated T cells in the non-TCR transgenic mice is insufficient to demonstrate this point, as there are multiple interpretations of this data beyond increased autoreactive T cells.
Referee #2
The manuscript by Kasler et al and presents an interesting transgenic new mouse model with a surprisingly strong phenotype in negative selection of thymocytes. The defect in negative selection is well documented using two different TCR transgenic mouse strains. Further, the authors convincingly document how multi-organ autoimmunity develops in the transgenic mice as a result of defective negative selection.
A weaker point in the manuscript is the analysis of the molecular mechanism how dominant HDAC7-deltaP prevents apoptosis of to be negatively selected thymocytes. Specifically, it would be useful to investigate the effect of antigenic peptide injection at earlier time points than the presented 2.5h ( Fig.3 ) and 3h (Fig.4) . Otherwise it is hard to tell whether e.g. reduced Erk phosphorylation or less Nur77 expression is the cause or the symptom. An additional option to address this would be transgenic overexpression of Bcl-2 in these investigated mice.
In addition, I have a few rather minor points in random order:
# It would be interesting to see and easily tested whether development of classical CD4 single positive NKT cell is affected in the HDAC7-deltaP Tg.
# Some awkward sentences should be double-checked P3 how are Tregs eliminated from the repertoire; P4 Errors in the coupling...; P5 Conversely, thymus-specific negative selection of HDAC7 ...; P9 these cells would be expected to be more likely ...
# Tregs are now called "Treg cells"
# Figure 5C should either show colon or no colon for both genotypes.
# The survival data in Fig. 5B , 6D,E, and 7C should shown as normal Kaplan Meier curves.
# In the abstract the link to AIRE deficiency and NOD mice is a far shot.
Referee #3 HDAC7 can shuttle between the nucleus and cytoplasm and TCR signaling induces nuclear export of HDAC7 in DP thymocytes. In the submitted manuscript, Verdin and colleagues investigated the importance of HDAC7 nuclear export on thymocyte development by generating a transgenic mouse in which exogenously expressed HDAC7 is constitutively localized in the nucleus (HDAC7-deltaP). The authors observed that transgenic thymocytes expressing HDAC7-deltaP had a block in negative selection, while positive selection was relatively normal. Impaired negative selection resulted in the escape of auto-reactive T cell in the periphery, leading to a lethal autoimmune syndrome. Mechanistically, gene expression arrays revealed that the induction of gene expression programs associated with negative selection are suppressed in transgenic DP thymocytes and that there is impaired activation of the MAP kinase pathway upon TCR triggering in DP thymocytes.
Overall, this is a nicely performed story that provides novel insight (i) into how negative selection during thymocyte development is regulated and (ii) about the role of HDAC7 in this process.
Specific comments:
(1) In Figure 1 , the authors show the phenotype of HDAC7-deltaP tg mice. However, a more comprehensive analysis of T cell development should be provided. Are there any changes in the expression levels of TCR/CD3, CD24 (HSA), CD69 or CD5 in the various subsets? What is the distribution between CD3hi and CD3lo cells between the CD8SP gate? It would also be informative to show a CD4/CD8 dot plot on TCRb-high and TCRb-low-gated thymocytes to get a better overview about the relative presence of various thymocyte subsets. (3) The authors show that genes required for negative selection are repressed in HDAC7-deltaP tg mice upon TCR stimulation. It would be interesting to know whether constitutive nuclear HDAC7 also blocks dexamethasone-induced deletion of DP thymocytes? Thus, the authors should inject dexamethasone into wt and HDAC7-deltaP tg mice and test whether there is a difference in the deletion of DP thymocytes.
(4) The authors conclude that nuclear HDAC7 represses genes required for negative selection and they provide experimental evidence to support the conclusion. However, wouldn't it be possible that HDAC7 also has a function in the cytoplasm that is required for negative selection (e.g. that HDAC7 acetylates certain proteins in the cytoplasm)? Why is MAP kinase pathway activation impaired? The authors suggest that HDAC7 regulates a "functional cassette of genes...that are required to allow MAP kinase activation" (page 12). However, it is possible that cytoplasmic HDAC7 acetylates signaling molecules and that this modification is required for MAP kinase activation. The authors should mention in the discussion section the possibility that HDAC7 might have a cytoplasmic function to indicate the possibility of yet unknown additional activities of HDAC7 beyond repressing genes in the nucleus.
(5) The authors should show how they gated for ISP cells (Fig. S1) Minor issue:
On page 5, last paragraph, 7th line from the bottom: the phrase "negative selection of HDAC7" in the sentence "Conversely, thymus-specific negative selection of HDAC7 results in ..." does not appear to be correct.
Referee#1:
WhilethedatashowingtheseverityofdominantTcell-dependentautoimmunity(Figures5-7) isveryconvincing,thereareseveralmajorissueswiththedatalinkingthisautoimmunitytoa specificdefectinnegativeselection: (Fig.2E )that showsthatCD4TcellnumbersintheperipheryarenearnormalinOT-2vs.OT-2XHDAC7ΔP mice.Secondly,wehavenowdemonstratedthedefectinMAPkinaseactivationandNur77 expressioninHDAC7-ΔPtransgenicthymocytesinanexvivosystem,whereinfluencesfrom peripheralTcellsarenotanissue( Fig.4C-D) .Lastly,wehaveshownthatbothupregulationof activationmarkersandproliferationarenormalinsplenicHDAC7-ΔPXOT-2Tcellsafterex vivostimulationwithOvapeptide( Fig.S2G-H (Fig.3)and3h(Fig.4) .Otherwiseitishardtotellwhethere.g. reducedErkphosphorylationorlessNur77expressionisthecauseorthesymptom.Anadditional optiontoaddressthiswouldbetransgenicoverexpressionofBcl2intheseinvestigatedmice.
Themainreasonweonlyevaluatedonetimepointindepthintheoriginalsubmissionwas theconsiderabletechnicaldifficultyinvolvedinobtainingenoughflow-sortedthymocytes fromallofthemicerequiredtodotheanalysiswithsufficientreplicates.Therefore,inorder toevaluatemoretimepointsmoreefficiently,wehaveswitchedtoamagneticbeadsorting strategyanddonethestimulationexvivo,allowingustoevaluatemultipletimepointswith thethymocytesfromonemouse. Inthisformat,whichalsoaddressesaconcernofReviewer#1describedabove,wehavenow shownthatthedefectinP38activationisdetectableasearlyas25minutespost-stimulation, beforeNur77,oneofthemostrapidlyandstronglyupregulatedtargetsofTCRsignaling,is detectablyinduced( Fig.4C-D) .ThepicturewithErkactivationislessclear-cutatearlytime points,withsignificantreductionofErkactivitynotbeingobserveduntil100minutes (Fig.4E ), althoughwesuspectthatmorerepetitionsoftheexperimentwouldshowsignificanceat50 minutesaswell(P=0.07,2-tailedpairedT-testfor4replicates).Importantly,wedidnotmean toimplyinournarrativethatallofthegeneexpressionchangesweobservedwerea consequenceratherthanacauseofthedefectinMAPkinaseactivation,nordowefeelthis findingwouldbeinanywaycriticaltothemodelweareadvancing.Rather,weassertthatasa consequenceoftheprimaryeffectofHDAC7-ΔPongeneexpression,theresponseoftheErk andP38pathwaysisdampenedinawaythatsignificantlybroadensthedefectinnegative selectionbeyondanydirecttargetsofHDAC7. 
#Tregsarenowcalled"Tregcells"
Wehavenowchangedallinstancesto"Tregs"
#Figure5Cshouldeithershowcolonornocolonforbothgenotypes.
ThecolonisinfactquiteabitsmallerintheWTanimal,butweagreethatitseemstohave beencutsomewhatclosertothecaecumthanintheHDAC7-ΔPanimal.Wehavenow truncatedtheimageoftheHDAC7-ΔPcolonatwhatweestimateisthesamelocation.
#ThesurvivaldatainFig.5B,6D,E,and7CshouldshownasnormalKaplanMeiercurves.
Thishasbeencorrectedintherevisedmanuscript.
#IntheabstractthelinktoAIREdeficiencyandNODmiceisafarshot.
Thislanguagehasbeenremovedfromtheabstract.
Referee#3:
(1)InFigure1,theauthorsshowthephenotypeofHDAC7-deltaPtgmice. Aswestatedinourresponsetothesimilarconcernraisedbyreviewer#1,wehavenow providedinformationaboutescapeofVα2-positive,CD4-positiveTcellsintotheperipheryof OT-2Xact-OvaXHDAC7-ΔPvs.OT-2Xact-Ovaanimals( Fig.2D-E) .Thesefigurepanelsalso showaminimal(notstatisticallysignificant)reductioninthenumbersofCD4/Vα2-positiveT cellsinthespleensofOT-2vs.OT-2XHDAC7-ΔPMice (Fig.4D) (5)TheauthorsshouldshowhowtheygatedforISPcells (Fig.S1) GatingforISPcellswasdoneusingexpressionofCD3εasthemarkerformaturevs.ISPcells (showninFig.S1C).
Onpage5,lastparagraph,7thlinefromthebottom:thephrase"negativeselectionofHDAC7" inthesentence"Conversely,thymusspecificnegativeselectionofHDAC7resultsin..."doesnot appeartobecorrect.
Reviewer#2alsospottedthiserror,whichhasbeenfixed.Wemeanttosay"deleted".
